Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection

Alessandra Viganò, Len Dally, Dorella Bricalli, Natascia Sala, Maria Pirillo, Marina Saresella, Daria Trabattoni, Stefano Vella, Mario Clerici, Nicola Principi

Research output: Contribution to journalArticle

Abstract

Clinical, virologic, and immunologic outcomes were analyzed in children with vertically transmitted human immunodeficiency virus (HIV) infection (n = 95) and clinical symptoms and evidence of immunosuppression to establish the efficacy of 18 months' treatment with stavudine, lamivudine, and indinavir. Children were naive for treatment with protease inhibitors and lamivudine and had minimal exposure to stavudine. At 1, 6, 12, and 18 months, the proportions of patients with HIV-RNA + count and percent increased significantly in both CDC immunologic class groups, but to a greater extent in the class 3 group. In the 12- to 18-month period, there were no significant changes within the groups. In both groups there was a steady increase in the proportion and number of children with positive skin test responses. Children in class 2 were more likely to have a positive delayed-type hypersensitivity response and a greater number of positive responses. Lymphocyte proliferative response to recall antigens improved significantly in all patients. The rate of increase in positive test results was faster in children in class 2 than in those in class 3. Only minor clinical events occurred during 18 months of therapy. Potent antiretroviral therapy achieves a sustained benefit in HIV-infected children, but immune reconstitution is more likely achieved in children with less advanced disease.

Original languageEnglish
Pages (from-to)675-682
Number of pages8
JournalJournal of Pediatrics
Volume135
Issue number6
Publication statusPublished - 1999

    Fingerprint

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Viganò, A., Dally, L., Bricalli, D., Sala, N., Pirillo, M., Saresella, M., Trabattoni, D., Vella, S., Clerici, M., & Principi, N. (1999). Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection. Journal of Pediatrics, 135(6), 675-682.